Fairvalue-Calculator Fairvalue-Calculator
EN DE

Vieworks Co (100120) Fair Value & Analysis

Healthcare · KR · Market cap 233B KRW

Price22,750 KRW
Fair Value42,255 KRW
Upside+85.7%
Quality95/100
Evidence: High Range 25,424 KRW – 53,861 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Vieworks Co (100120) currently trades at 22,750 KRW, while our model-based Fair Value estimate is 42,255 KRW — implying the stock looks roughly 85.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions. The company offers X-ray detectors and image processing technologies for general radiography system, dental and surgical C-arm systems, radiography and fluoroscopy system, veterinary radiography system, industrial inspection instrument, and other applications. It also provides industrial cameras; and bio imaging systems comprising in vivo imaging systems under the VISQUE brand. The company was formerly known as Raysis Co., Ltd. and changed its name to Vieworks Co., Ltd. in November 2006. Vieworks Co., Ltd. was founded in 1999 and is headquartered in Anyang-si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Vieworks Co (100120) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 42,255 KRW versus a price of 22,750 KRW — about +86% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 100120?
Our 21-model fair value for Vieworks Co is 42,255 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 22,750 KRW.
What is the quality score of 100120?
Vieworks Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.